Literature DB >> 10372544

Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: sequencing based typing of HLA-DRB genes.

K Kotsch1, J Wehling, R Blasczyk.   

Abstract

In this paper, we present a novel sequencing based typing strategy for the HLA-DRB1, 3, 4 and 5 loci. The new approach is based on a group-specific amplification from intron 1 to intron 2 according to the serologically-defined antigens. For this purpose, we have determined the 3' 500 bp-fragment of intron 1 and the 5' 340 bp-fragment of intron 2 of all serological antigens and their most frequent subtypes. We discovered a remarkably conserved diversity characterized by lineage-specific sequence motifs. This lineage-specificity of non-coding motifs in the 1st and 2nd intron offered the possibility to establish a clear serology-related amplification strategy. The method allows the complete analysis of the 2nd exon and the definition of the cis/trans linkage of sequence motifs by intron-mediated polymerase chain reaction (PCR)-based separation of the haplotypes in nearly all serologically heterozygous samples. In particular, the non-coding variabilities between the DR52-associated DRB1 groups made their independent amplification possible. Thus, compared to the standard procedures using exon-based amplification primers, the groups DR3, DR12, some DR13 alleles (1301, 1302) and the DR14 group could be amplified by specific primer mixes. The DR8 could be amplified with an individual primer mix not co-amplifying the DR12. The DR11 and DR13 did not show any individual motif in intron 1 or intron 2. In order to achieve a separate amplification, they had to be amplified by multispecific primer mixes (DR3/11/13/14; DR3/11/13 or DR11/13/14) excluding the other haplotype. Thus, exclusively the alleles in rare DR11,13 heterozygosities without a DRB1*1301 or 1302 could not be amplified separately. Fourteen primer mixes are used to amplify the specificities DR1-14, and 6 primer mixes for the specificities DR51-53. The sequence homology of the 3' end of intron 1 facilitated the application of only three different sequencing primers for all DRB alleles.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10372544     DOI: 10.1034/j.1399-0039.1999.530505.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  28 in total

1.  Simultaneous genotyping of DRB1/3/4/5 loci by oligonucleotide microarray.

Authors:  Ye Bang-Ce; Chu Xiaohe; Fan Ye; Li Songyang; Yin Bincheng; Zuo Peng
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

2.  HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women.

Authors:  Jens Kjeldsen-Kragh; Thomas L Titze; Benedicte Alexandra Lie; John T Vaage; Mette Kjær
Journal:  Blood Adv       Date:  2019-04-09

3.  Estimation of size of cord blood inventory based on high-resolution typing of HLAs.

Authors:  E Y Song; J Y Huh; S Y Kim; T G Kim; S Oh; J H Yoon; E Y Roh; M H Park; M S Kang; S Shin
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

4.  DQB1*060101 may contribute to susceptibility to immunoglobulin A nephropathy in southern Han Chinese.

Authors:  Wei Wang; Ming Li; Li Wang; Xueqing Yu
Journal:  Front Med       Date:  2016-12-23       Impact factor: 4.592

5.  Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.

Authors:  Lisa E Creary; Sandra G Guerra; Winnie Chong; Colin J Brown; Thomas R Turner; James Robinson; Will P Bultitude; Neema P Mayor; Steven G E Marsh; Katsuyuki Saito; Kevin Lam; Jamie L Duke; Timothy L Mosbruger; Deborah Ferriola; Dimitrios Monos; Amanda Willis; Medhat Askar; Gottfried Fischer; Chee Loong Saw; Jiannis Ragoussis; Martin Petrek; Carles Serra-Pagés; Manel Juan; Catherine Stavropoulos-Giokas; Amalia Dinou; Reem Ameen; Salem Al Shemmari; Eric Spierings; Ketevan Gendzekhadze; Gerald P Morris; Qiuheng Zhang; Zahra Kashi; Susan Hsu; Sridevi Gangavarapu; Kalyan C Mallempati; Fumiko Yamamoto; Kazutoyo Osoegawa; Tamara Vayntrub; Chia-Jung Chang; John A Hansen; Marcelo A Fernández-Viňa
Journal:  Hum Immunol       Date:  2019-03-04       Impact factor: 2.850

6.  Sequence variations in the transcriptional regulatory region and intron1 of HLA-DQB1 gene and their linkage in southern Chinese ethnic groups.

Authors:  Yunping Xu; Qingsong Hu; Zehuan Liu; Yang Shen; Xiaoyi Liu; Bin Lin; Yuping Wu; Shangwu Chen; Anlong Xu
Journal:  Immunogenetics       Date:  2005-09-29       Impact factor: 2.846

7.  HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of self-perpetuating arthritis.

Authors:  Bettina Panagiota Iliopoulou; Mireia Guerau-de-Arellano; Brigitte T Huber
Journal:  Arthritis Rheum       Date:  2009-12

8.  Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.

Authors:  So-Young Bang; Tae-Un Han; Chan-Bum Choi; Yoon-Kyoung Sung; Sang-Cheol Bae; Changwon Kang
Journal:  Arthritis Res Ther       Date:  2010-06-10       Impact factor: 5.156

9.  Opposing effects of the D70 mutation and the shared epitope in HLA-DR4 on disease activity and certain disease phenotypes in rheumatoid arthritis.

Authors:  N A Shadick; J E Heller; M E Weinblatt; N E Maher; J Cui; G Ginsburg; J Coblyn; R Anderson; D H Solomon; R Roubenoff; A Parker
Journal:  Ann Rheum Dis       Date:  2007-05-09       Impact factor: 19.103

10.  CYP1A2 genotype and rheumatoid arthritis in Koreans.

Authors:  Marilyn C Cornelis; Sang-Cheol Bae; Il Kim; Ahmed El-Sohemy
Journal:  Rheumatol Int       Date:  2009-07-05       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.